Amgen Impairment of Goodwill and Other Intangibles decreased by 100.0% to $0.00 in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 100.0%, from $800.00M to $0.00. This is a positive signal — lower values indicate better performance for this metric.
High impairment charges signal poor historical capital allocation or a decline in the value of acquired business units.
This captures non-cash charges taken when the carrying value of goodwill or intangible assets exceeds their fair market...
Peer companies with frequent M&A activity will show similar, though infrequent, impairment events.
pm_goodwill_and_intangible_impairment| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $212.75M | $212.75M | $212.75M | $212.75M | $68.00M | $0.00 | $61.00M | $30.00M | $800.00M | $400.00M | $0.00 |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -68.0% | -100.0% | — | -50.8% | >999% | -50.0% | -100.0% |
| YoY Change | — | — | — | — | -68.0% | -100.0% | -71.3% | -85.9% | >999% | +555.7% | -100.0% |